Deadline: 21-Apr-2026
The European Commission invites applications for grants (€8–60 million) to fund research on disease determinants, prevention, and early intervention. The program supports collaborative consortia worldwide to develop innovative tools, vaccines, monitoring systems, and strategies that improve patient outcomes and healthcare system preparedness.
Overview
The European Commission seeks proposals for research and innovation that enhance understanding of health determinants and priority disease areas. The initiative emphasizes preventive care, early diagnosis, and innovative health strategies to improve patient outcomes and strengthen healthcare systems.
Key objectives include:
- Supporting preventive treatment and early disease intervention before symptoms appear.
- Promoting prevention, early diagnosis, and understanding of disease mechanisms for cost-effective healthcare strategies.
- Facilitating regular monitoring of critical health parameters using validated tools.
- Developing new vaccine strategies tailored to specific sub-populations.
- Enhancing healthcare system preparedness for disease outbreaks.
- Strengthening the competitiveness of the EU health industry, technological leadership, and digital transformation.
- Promoting holistic approaches, including One Health initiatives.
Scope of Funded Research
- Pre-competitive research: Novel tools, methods, and technologies to support prevention, interception, diagnosis, treatment, management, and patient recovery.
- Cross-sector collaboration: Public-private partnerships reflecting integrative, multidisciplinary approaches.
- Targeting unmet public health needs: Projects should address high disease burden, economic impact, or transformational innovation potential.
- Translational focus: Ability to implement research outcomes into healthcare ecosystems or industrial processes.
- Landscape analysis: Identify overlaps with existing initiatives and potential synergies.
Funding Details
- Project funding per initiative: €8,000,000 – €60,000,000
- Total program budget: €110,000,000
- Eligible participants: Any legal entity worldwide, including non-associated third countries and international organizations, compliant with Horizon Europe Regulation.
How to Apply
- Form a collaborative consortium: Include public and private partners with complementary expertise.
- Define research objectives: Align with disease prevention, early diagnosis, and system preparedness.
- Develop translational plan: Demonstrate how research results will be implemented in healthcare or industry.
- Conduct a landscape analysis: Avoid duplication and identify synergies with existing initiatives.
- Prepare proposal and budget: Follow Horizon Europe submission guidelines.
Common Mistakes to Avoid
- Proposing research without translational or implementation potential.
- Failing to include cross-sectoral or public-private collaboration.
- Overlooking landscape analysis, risking duplication with ongoing initiatives.
- Not addressing unmet public health needs or disease burden.
- Ignoring Horizon Europe eligibility requirements.
FAQs
1. Who can apply for this grant?
Any legal entity worldwide, including non-associated third countries and international organizations, meeting Horizon Europe requirements.
2. What is the funding range per project?
€8,000,000 to €60,000,000.
3. What is the total program budget?
€110,000,000.
4. Are international collaborations encouraged?
Yes, collaborative public-private consortia with integrative, cross-sectoral expertise are required.
5. What types of research are eligible?
Pre-competitive research on prevention, early diagnosis, vaccine development, monitoring tools, treatment, and patient recovery.
6. Are there any thematic priorities?
Yes, projects should focus on disease determinants, preventive strategies, early intervention, and system preparedness, with consideration for One Health approaches.
7. Is translational potential required?
Yes, proposals must demonstrate the ability to implement results in healthcare systems or industrial processes.
Why This Funding Matters
This program enables innovative, cross-disciplinary research that enhances early detection, disease prevention, and healthcare system preparedness. It supports the EU’s digital and technological transformation in health while promoting global collaboration and improving patient outcomes.
Conclusion
The European Commission Health Determinants and Disease Research grant is a strategic opportunity for consortia to advance preventive, early-intervention, and transformative health research. By integrating multidisciplinary expertise and focusing on implementable solutions, applicants can contribute to better patient care, healthcare resilience, and global health innovation.
For more information, visit European Commission.